SONIA VASQUEZ: Open Payments
NPI 1619184009 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 19 payments from 7 companies in 2025. Trend: 2023 $980 · 2024 $1,116 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 7 | $221 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
| Intercept Pharmaceuticals, Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: REZDIFFRA, DUPIXENT, OCALIVA, XIFAXAN, IQIRVO, LINZESS, RINVOQ.
Industry payments across CA — which companies pay providers there.
